Skip to Main Content

Paper Details

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.
J Mol Cell Cardiol
22
2019

Datasets

Release 1.2